News from longevity biotech, inc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

Jul 16, 2018, 13:01 ETLongevity Biotech Initiates Clinical Neuroinflammation Biomarker Study at the Department of Veterans Affairs to Investigate Immune Related Aspects of Parkinson's Disease With Continued Support From the Michael J. Fox Foundation

Longevity Biotech, Inc. (LBT) is launching a new clinical study to identify specific immune and inflammatory markers that could potentially be used...


Oct 27, 2017, 08:00 ETLongevity Biotech Awarded Grant From National Multiple Sclerosis Society to Evaluate LBT-3627 as a Novel Drug Candidate for Multiple Sclerosis

Longevity Biotech, Inc. (LBT) has received an award from the National Multiple Sclerosis Society through Fast Forward, the Society's commercial...


Oct 11, 2017, 14:15 ETLongevity Biotech Granted US Patent Covering Hybridtide Platform Technology for Stabilized Peptide Therapeutics

Longevity Biotech, Inc. (LBT) is pleased to announce that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 9,782,454...


Feb 07, 2017, 07:00 ETLongevity Biotech and University of Nebraska Medical Center Awarded Continuing Grant from the Michael J. Fox Foundation for Parkinson's Research

Longevity Biotech, Inc. (LBT) and the University of Nebraska Medical Center (UNMC) are pleased to announce support by The Michael J. Fox Foundation...